Malin Corporation | MLC - Assets


Malin Corporation reported EUR198.5M in Assets for its fiscal semester ending in December of 2024.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
ALKERMES USD 2.49B 157.48M Dec/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Eurofins Scientific SE EUR 10.99B 399.1M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Ovoca Bio EUR 1.66M 9.75M Jun/2025
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 261.04M 15.96M Dec/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 383.53M 13.34M Dec/2025